Latest stories on LEXX
Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
StockTitan28 · bearishgeneral
Lexaria Bioscience Corp. (LEXX) files 8-K
SEC 8-K50 · neutralgeneral
Lexaria Bioscience announces exercise of warrants for $5.9M in proceeds
The Fly42 · neutralgeneral
Lexaria Bioscience announces $5.9M warrant exercise
Seeking Alpha28 · bearishgeneral
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
StockTitan28 · bearishgeneral
Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralgeneral
Lexaria Bioscience advances 12% on Australian tax rebate
Seeking Alpha68 · bullishgeneral
Lexaria receives $2.6M R&D tax rebate from Australian Tax Office; shares up over 14%
Seeking Alpha67 · bullishgeneral
Lexaria Bioscience receives $2.6M tax rebate payment
The Fly59 · neutralgeneral
Lexaria Bioscience Corp. (LEXX) files 8-K
SEC 8-K50 · neutralgeneral
Lexaria Receives USD$2.6 Million Tax Rebate Payment
StockTitan59 · neutralgeneral
Lexaria DehydraTECH 3.0 Boosts GLP-1 Drug Absorption in 2026 Study
TipRanks63 · neutralproduct/pr
DehydraTECH(TM)-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2
StockTitan63 · neutralproduct/pr
Lexaria Bioscience Regains Nasdaq Compliance, Stabilizing Listing
TipRanks59 · neutralgeneral
Lexaria Bioscience Corp. (LEXX) files 8-K
SEC 8-K50 · neutralgeneral
Lexaria Bioscience enters MTA with PegBio
The Fly63 · neutralm&a
Lexaria Enters a Material Transfer Agreement With PegBio
StockTitan63 · neutralproduct/pr
Lexaria Bioscience Corp. (LEXX) files 8-K
SEC 8-K28 · bearishgeneral
Kneat Shareholders Strongly Back Thoma Bravo Acquisition Deal
TipRanks63 · neutralm&a
Lexaria Bioscience Corp. (LEXX) files 8-K
SEC 8-K50 · neutralgeneral
Lexaria Announces Effective Date for Reverse Stock Split
StockTitan38 · neutralgeneral
Lexaria Updates Business Development | LEXX Stock News
StockTitan56 · neutralproduct/pr
Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule | LEXX Stock News
StockTitan63 · neutralproduct/pr
Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule | LEXX Stock News
StockTitan63 · neutralproduct/pr
GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand | LEXX Stock News
StockTitan58 · neutralproduct/pr